Neoplasms

Skin and Connective Tissue Diseases

All Conditions

Breast Neoplasms

Breast Diseases

Skin Diseases

Antineoplastic Agents

All Drugs and Chemicals

Capecitabine

Taxane

Antimetabolites

larotaxel

oral, twice daily, Day 1-Day 14 of a 21-day cycle

capecitabine

The goal of this phase I-II clinical research study is to find the highest safe dose of XRP9881 and capecitabine that can be given in combination in the treatment of metastatic breast cancer in patients who have been previously treated by taxanes and anthracyclines. The safety and effectiveness of this combination will also be studied. Patients participating in the study will be asked to give additional blood samples to look at the level of study drugs in the blood.

Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer

A Dose-escalating, Multicenter, Single Arm, Open-Label Study of XRP9881 in Combination With Capecitabine (Xeloda), in Metastatic Breast Cancer Patients With Disease Progressing After Anthracycline and Taxane Therapy

Sanofi

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer	NCT00327743	Breast Cancer Cancer	larotaxel capecitabine	18 Years -	Sanofi
Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer	NCT00327743	Breast Cancer Cancer	larotaxel capecitabine	18 Years -	Sanofi

Spots Global Cancer Trial Database for larotaxel

Every month we try and update this database with for larotaxel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for larotaxel

Every month we try and update this database with for larotaxel cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for larotaxel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.